Cyclosporin A cas no:59865-13-3

Synonyms: 1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine];Ciclosporin;Ciclosporinum [INN-Latin];Cipol N;Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-;Cyclosporine;Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl);Sang 35;Sandimmune (TN);S 7481F1;Restasis;30-ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-dipropan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Neoral;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-pent-3-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-3,6,9,18,24-pentakis(2-methylpropyl)-21-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Sigmasporin Microoral;Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl);Cyclosporin;Consupren;cyclophorine;sandimmun;Sandimmun Neoral;Prestwick_731;Ciclosporin (JP14);Neoplanta;Neoral (TN);Sang-35;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-dipropan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Sandimmune;Antibiotic S 7481F1;OL 27-400;
NameCyclosporin A
CAS59865-13-3
Synonyms1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine];Ciclosporin;Ciclosporinum [INN-Latin];Cipol N;Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-;Cyclosporine;Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl);Sang 35;Sandimmune (TN);S 7481F1;Restasis;30-ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-dipropan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Neoral;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-pent-3-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-3,6,9,18,24-pentakis(2-methylpropyl)-21-propan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Sigmasporin Microoral;Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl);Cyclosporin;Consupren;cyclophorine;sandimmun;Sandimmun Neoral;Prestwick_731;Ciclosporin (JP14);Neoplanta;Neoral (TN);Sang-35;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-dipropan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Sandimmune;Antibiotic S 7481F1;OL 27-400;
Molecular FormulaC62H111N11O12
Molecular Weight1202.61124
AppearanceWhite Powder
storage temp2-8°C
Hazard T:Toxic
Risk R45;R60;R22
Safety
Hazard Codes?of Cyclosporine (CAS NO.59865-13-3):?
T,
Xn
Risk Statements: 45-60-22-40?
R45: May cause cancer.?
R60: May impair fertility.?
R22: Harmful if swallowed.?
R40: Limited evidence of a carcinogenic effect.
Safety Statements: 53-45-36/37-24/25-22?
S53: Avoid exposure - obtain special instructions before use.?
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)?
S36/37: Wear suitable protective clothing and gloves.?
S24/25: Avoid contact with skin and eyes.?
S22: Do not breathe dust.
WGK Germany: 3
RTECS: GZ4120000
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
human |
TDLo |
oral |
12mg/kg (12mg/kg) |
VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION
ENDOCRINE: ANTIDIURESIS |
Journal of Hypertension. Vol. 11, Pg. 1209, 1993. |
man |
TDLo |
oral |
14286ug/kg (14.286mg/kg) |
BEHAVIORAL: TREMOR
BEHAVIORAL: EXCITEMENT
CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) |
Annals of Pharmacotherpy. Vol. 34, Pg. 405, 2000. |
man |
TDLo |
oral |
20mg/kg/2D-I (20mg/kg) |
BEHAVIORAL: HEADACHE
VASCULAR: ACUTE ARTERIAL OCCLUSION
LUNGS, THORAX, OR RESPIRATION: CYANOSIS |
Lancet. Vol. 2, Pg. 1092, 1986. |
man |
TDLo |
parenteral |
20mg/kg/5D-I (20mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE
SENSE ORGANS AND SPECIAL SENSES: DIPLOPIA: EYE
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE |
American Journal of Ophthalmology. Vol. 126, Pg. 607, 1998. |
man |
TDLo |
unreported |
30mg/kg/4D-I (30mg/kg) |
KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" |
Annals of Internal Medicine. Vol. 107, Pg. 786, 1987. |
mouse |
LD50 |
intravenous |
96mg/kg (96mg/kg) |
? |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 17, Pg. 365, 1986. |
mouse |
LD50 |
oral |
2329mg/kg (2329mg/kg) |
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
SKIN AND APPENDAGES (SKIN): HAIR: OTHER
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Archives of Toxicology. Vol. 53, Pg. 107, 1983. |
rabbit |
LD50 |
intravenous |
10mg/kg (10mg/kg) |
? |
Toxicologic Pathology. Vol. 14, Pg. 73, 1986. |
rabbit |
LD50 |
oral |
> 1gm/kg (1000mg/kg) |
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
SKIN AND APPENDAGES (SKIN): HAIR: OTHER
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Archives of Toxicology. Vol. 53, Pg. 107, 1983. |
rat |
LD50 |
intraperitoneal |
147mg/kg (147mg/kg) |
? |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 17, Pg. 365, 1986. |
rat |
LD50 |
intravenous |
24mg/kg (24mg/kg) |
? |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 17, Pg. 365, 1986. |
rat |
LD50 |
oral |
1480mg/kg (1480mg/kg) |
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
SKIN AND APPENDAGES (SKIN): HAIR: OTHER |
Archives of Toxicology. Vol. 53, Pg. 107, 1983. |
rat |
LD50 |
subcutaneous |
286mg/kg (286mg/kg) |
? |
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 17, Pg. 365, 1986. |
women |
TDLo |
oral |
62500ug/kg/5D (62.5mg/kg) |
KIDNEY, URETER, AND BLADDER: OTHER CHANGES |
Lancet. Vol. 1, Pg. 1221, 1986. |
women |
TDLo |
oral |
1911mg/kg/91W (1911mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: COMA
KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" |
British Journal of Rheumatology. Vol. 33, Pg. 90, 1994. |